Publications
- Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways2022 | First Faculty of Medicine
- Azacitidine Switch to Lenalidomide Eradicated the TP53/ CDKN2A Co-Mutated Clone and Induced Long-Term Erythroid Response in Del(5q) MDS2019 | First Faculty of Medicine
- Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas2017 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders2017 | First Faculty of Medicine, Faculty of Mathematics and Physics
- The ISWI ATPase Smarca5 (Snf2h) Is Required for Proliferation and Differentiation of Hematopoietic Stem and Progenitor Cells2017 | First Faculty of Medicine
- Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years2016 | First Faculty of Medicine, Second Faculty of Medicine
- Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia2016 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research2014 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents2014 | First Faculty of Medicine
- MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia2011 | First Faculty of Medicine
Loading network view...
